Closure device for tissue opening - Patent application

A closure device with collapsible mesh elements and a tethered system addresses the challenge of sealing tissue openings in minimally invasive procedures, ensuring secure and efficient sealing and healing.

JP7584483B2Active Publication Date: 2024-11-15MUFFIN INC
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
JP2022163757
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2017-05-23
Filing Date
2022-10-12
Publication Date
2024-11-15
Estimated Expiration
2038-05-23

AI Technical Summary

Technical Problem

Existing minimally invasive surgical procedures face challenges in effectively closing tissue openings due to the difficulty in suturing or sealing holes, especially when both sides of the hole must be closed, and existing devices are cumbersome to install.

Method used

A closure device comprising two collapsible mesh elements with tethered ends, which are delivered minimally invasively using a delivery system, allowing for secure sealing of tissue openings by expanding and compressing the mesh elements against the tissue.

Benefits of technology

The device facilitates efficient and secure sealing of tissue openings with minimal invasiveness, promoting tissue fusion and healing, and can be visualized using fluoroscopy for precise deployment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007584483000001
    Figure 0007584483000001
  • Figure 0007584483000002
    Figure 0007584483000002
  • Figure 0007584483000003
    Figure 0007584483000003
Patent Text Reader

Abstract

To provide a device for suturing and closing a hole, which can be easily used even in a limited space. An embodiment of a closure device (22) for closing a tissue hole, such as a hole in a right atrial appendage, is shown and described. The closure device (22) includes a first mesh closure member (30) and a second mesh closure member (32) and a tether (64) connecting them. An enlarged end (66) of the tether (64) is anchored to a first end (38) of the first mesh closure member (30), and the enlarged end (68) of the tether (64) is within a central volume (42) of the second mesh closure member (32). The first mesh closure member (30) is adapted to engage a distal surface of tissue having a hole, the second mesh closure member (32) is adapted to engage a proximal surface of the tissue, and the tether (64) is adapted to pass through the hole.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] This application discloses structures and methods for minimally invasively closing internal tissue openings. More specifically, a closure device having two connected mesh structures that can be used to close minimally invasive surgical openings in the heart or other organs is disclosed. [Background technology]

[0002] For many procedures involving the placement of medical devices inside a patient, or for other therapeutic or diagnostic purposes, minimally invasive surgical procedures have been developed as a way to reduce trauma to the patient. In such procedures, an aperture is made and accessed with a catheter or similar device, through which the therapeutic device is delivered to the site of interest. Once the procedure, or part of the procedure, is completed, the access catheter is removed and the aperture is repaired.

[0003] Devices and methods have been described for suturing such holes closed. However, such devices and methods commonly are extremely difficult to use in such confined spaces. To avoid sutures, devices have been developed to plug or cover such holes and allow the holes to heal naturally, or to incorporate part or all of such a plug into the tissue. While such items are effective, they can be difficult to place, especially when both sides of the hole must be closed.

[0004] This disclosure addresses these issues. Summary of the Invention

[0005] Among other things, a closure device is disclosed that includes a distal collapsible mesh element, a proximal collapsible mesh element, and a tether or stem that is used to connect the two mesh elements and pull them together with the hole to be sealed between them. The distal mesh element has two ends that are everted into the interior of the mesh body. The mesh fibers are fused together or otherwise narrowed at each end by a bonding or welding operation such as shape setting with heat. The fused ends may have embedded therein a radiopaque marker (e.g., a cylindrical marker). In certain embodiments, both ends are everted into the body of the distal mesh element. The distal end of the distal mesh element is used to anchor the distal end of the tether or stem. The proximal end of the distal mesh may be covered (internally or externally) with a material (e.g., small intestinal submucosa (SIS)) to seal and / or promote healing.

[0006] The proximal mesh element has a distal end that is everted into the body of the proximal mesh element. This end is fused in the same or similar manner as the end of the distal mesh element and may also have a radiopaque marker. The distal end of the proximal mesh element may also be covered (internally or externally) with a material to seal and / or promote healing. In certain embodiments, the proximal end of the proximal mesh element is also fused or otherwise narrowed and includes a radiopaque marker, but is not everted. The proximal fused or narrowed end serves as the final conduit for the tether.

[0007] The tether has a distal end that may be enlarged (e.g., has a bead, a knot, or a knot) that can be secured to the distal end of the distal mesh element, and a cross-sectional enlargement (e.g., a bead, a knot, or a knot) at or near the proximal end of the tether. The tether also has a loop feature that is part of or adjacent to the proximal enlargement to allow attachment to a trigger or control wire in certain embodiments. A wire is used to pull the tether through the proximal end of the proximal mesh element as the delivery tool or device pushes and compresses the proximal mesh element. The proximal enlargement is pulled through the fused proximal end of the proximal mesh element to provide a lock or stop for the proximal mesh element when tension on the tether is released.

[0008] The delivery tool delivers the mesh elements in a stacked fashion. The closure device is stacked in the delivery tool with the distal mesh element in the distal peel-away catheter (e.g., 14 French) and the proximal mesh element in the sheath (e.g., 12 French). When the delivery tool is inserted through the hole to be closed and into the sheath secured by the balloon on the distal side of the hole, the peel-away catheter is peeled away so that the distal mesh element sits in the through-hole sheath and is pushed by the sheath holding the proximal mesh element. The distal mesh element is pushed out of the through-hole sheath to a site distal to the hole to be sealed. The tether is then slightly retracted, which serves to compress the distal mesh element against the sheath holding the proximal mesh element. The distal mesh element thereby expands. After the balloon is deflated, the two sheaths are pulled back through the hole, pulling the distal mesh element against the tissue to seal the hole.

[0009] In embodiments where one or both sheaths contain a fluid pathway, contrast may be advanced through the pathway to the site to allow visualization (e.g., by fluoroscopy) to confirm the seal created by the distal mesh element. After a seal is confirmed and the sheath tip is confirmed to be on the proximal side of the hole, the proximal mesh element is pushed out of its sheath, either by using a smaller inner tube or sheath (e.g., 9 French) alone or by further retracting the sheath that held the proximal mesh element. Tension is maintained on the tether or stem throughout via the control wire to ensure that the distal mesh element maintains a seal on the hole. The inner tube or sheath continues to push the proximal end of the proximal mesh element, advancing it over the control wire and finally beyond the proximal extension of the tether or stem, locking the mesh elements together. Once a final contrast injection is performed and sealing of the hole is confirmed, the end of the control wire is released, allowing the loop to unwind from the tether or stem end.

[0010] In certain embodiments, the tether or stem may have multiple extensions (e.g., knots, beads, or knots) to allow for varying amounts of tightening of the mesh elements together. The proximal end of the proximal mesh element may have relief cuts to allow for some stretching as the tether or stem extension(s) are pulled through it, and / or may have tapered holes to aid in unidirectional passing movement of the tether or stem extension(s). Other gripping, attachment, or backstopping or minimizing features, such as barbs, prongs, corkscrews, etc., may be used on the proximal end of the proximal mesh element to engage the tether or stem. The handle of the delivery device or tool may have one or more actuators or other mechanisms to facilitate performing the deployment steps in the correct sequence and to minimize the risk of premature deployment or release of any component during the procedure.

[0011] As an example, a closure for an opening in tissue can include a first closure element having a first mesh enclosure with a distal first narrowed end and a proximal second narrowed end and a central volume. Each of the first and second ends is everted to lie within the central volume of the first mesh enclosure, and each of the first and second ends is surrounded by an exterior surface of each of the first mesh enclosures. A second closure element has a second mesh enclosure with a distal third narrowed end and a proximal fourth narrowed end and a central volume. The third end is everted to lie within the central volume of the second mesh enclosure, and each of the third and fourth ends is surrounded by an exterior surface of each of the second mesh enclosures. A tether joins the first and second closure elements in an initial configuration prior to delivery of the first and second closure elements to the opening. The tether has a first enlarged end and a second enlarged end and extends through the first narrowed end, the second narrowed end, and the third narrowed end such that the first enlarged end of the tether is adjacent or engaged with the first end and outside the first closure element and the second enlarged end of the tether is within a central volume of the second closure element, The first closure element is adapted to engage a distal surface of tissue having an opening, the second closure element is adapted to engage a proximal surface of tissue, and the tether is adapted to pass through the opening.

[0012] Materials for the mesh and tethers or stems for the occlusion elements are desirably bioabsorbable. As the occlusion elements are formed or prepared, they may be subjected to a heat annealing or shape-setting process to allow them to naturally expand when deployed from the delivery device even when compressed or otherwise contained within the delivery device.

[0013] A sheet of bioabsorbable material may be secured to the first closure element adjacent to or over the second narrowed end. Such a sheet may be secured to an exterior portion of the first mesh enclosure. The enlarged end of the tether may be or include a bead or knot. A control wire may be looped through the second enlarged end of the tether and pass through the fourth narrowed end. The closure device is preferably initially housed within the delivery device. The ends of the first closure element may be aligned with each other and / or the ends of the second closure element may be aligned with each other. In other embodiments, the ends of the first closure element may be laterally offset relative to each other, or one of the ends may be larger in diameter than the other.

[0014] One embodiment of a device for closing an opening in tissue includes a delivery device having a first peel-away catheter, a second tube within the first peel-away catheter, and a pusher tube within the second tube, with a closure device as disclosed herein housed within the delivery device. For example, a first closure element may be within the first peel-away catheter and a second closure element within the second tube. A control line may be looped through the second enlarged end of the tether. A control cannula may extend through the pusher tube with the control line extending through the control cannula. The control line may extend from the control cannula and fold back from the second enlarged end of the tether back into the control cannula such that the free end of the control line is within the control cannula. [Brief description of the drawings]

[0015] [Figure 1] 1 is a perspective view of an embodiment of a closure device described herein. [Diagram 2] 2 is a side view of an embodiment of a mesh portion before being formed into a portion of the embodiment of FIG. 1. [Diagram 3] 2 is a side partial cross-sectional view of a portion of the embodiment of FIG. 1. [Figure 4] 2 is a side partial cross-sectional view of a portion of the embodiment of FIG. 1 having an alternative joining member. [Diagram 5] 2 is a side partial cross-sectional view of an alternative closure element that may be used in the embodiment of FIG. 1. [Figure 6] 2 is a side partial cross-sectional view of an alternative closure element that may be used in the embodiment of FIG. 1. [Figure 7] 2 is a side partial cross-sectional view of an alternative closure element that may be used in the embodiment of FIG. 1. [Figure 8] 2 is a side partial cross-sectional view of a delivery device having an embodiment of the closure device of FIG. 1 housed therein during initial insertion into a patient. [Figure 9] 9 is a view of the embodiment of FIG. 8 at a later stage of deployment as compared to FIG. 8. [Figure 10] 9 is a view of the embodiment of FIG. 8 at a later stage of deployment as compared to FIG. [Figure 11] 11 is a view of the embodiment of FIG. 8 at a later stage of deployment compared to FIG. 10. [Figure 12] 12 is a view of the embodiment of FIG. 8 at a later stage of deployment compared to FIG. 11. [Figure 13] 9 is a schematic representation of a portion of the delivery device embodiment shown in FIG. 8. [Figure 14] 9 is a side partial cross-sectional view of a portion of the delivery device embodiment of FIG. 8 having additional structure. [Figure 15] 9 is a side partial cross-sectional view of a portion of the delivery device embodiment of FIG. 8 having additional structure. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0016] For the purposes of promoting an understanding of the principles of the disclosure, reference will now be made to the embodiments illustrated in the drawings and specific language will be used to describe the embodiments, without the understanding, however, that no limitation on the scope of the claims is intended, and that variations and modifications of the apparatus and methods illustrated, and further applications of the principles of the disclosure set forth therein, are hereby recognized as would normally occur to one skilled in the art to which the disclosure pertains.

[0017] Referring generally to the drawings, there are shown embodiments of portions of a system 20 for closing an opening in tissue, for example, cardiac tissue. Such a system may include one or both of a closure device 22 and a placement device 24. As discussed further below, the closure device 22 is initially placed within the placement device 24. Once the placement device 24 is adjacent to or passed through the tissue opening, the closure device 22 is advanced out of the placement device 24 to cover the tissue opening and secured in place to allow or promote healing.

[0018] The closure device 22 in the illustrated embodiment is a two-piece device having a first or distal closure element 30 and a second or proximal closure element 32. "Distal" and "proximal" in this context refer to the relative position of the closure device 22 and / or placement device 24 relative to the direction of travel, with "distal" generally meaning toward or beyond the tissue hole or opening to be closed and "proximal" generally meaning toward the practitioner along that direction of travel. The closure element 30 is intended to engage and cover the tissue opening at the distal surface of the tissue, i.e., beyond the hole through the tissue. The closure element 32 is intended to engage and cover the tissue opening at the proximal surface of the tissue, i.e., the side first approached by the placement device 24. The closure elements 30 and 32 are joined together prior to insertion into a patient's body or, in certain embodiments, onto or into a delivery device, as discussed further below.

[0019] The occlusion element 30 is made of a mesh 34 in the illustrated embodiment, which in certain embodiments is a bioabsorbable, non-bioresorbable, and / or biological material. Such materials may be or include polypropylene, polyethylene, glycolide / L-lactide copolymer, PTFE, nylon, polyurethane, PEEK, PLGA, PGA, polycaprolactone, carbotan, polydioxanone, or copolymers of such components. The depicted mesh 34 includes multiple interstices 36 along the solid yet flexible material that have or resemble the appearance of crisscrossed strand(s) or similar linear member(s) 37.

[0020] The closure element 30 has a first end 38 and a second end 40, which are narrowed or closed in the illustrated embodiment. In one embodiment, a sheet or length of mesh 34 is rolled or otherwise formed into a cylindrical or other longitudinally closed shape having open ends 38 and 40 opposite each other about an axis. In such an embodiment, the mesh 34 has a central volume 42 between the ends 38 and 40. The end 38 is narrowed or closed to form a tube (e.g., with a passage), a closed mass, or other tip. For example, the narrowing or closing can be achieved by heat shrinking a portion of the end 38 to form a tube with a passage having a diameter substantially smaller than the standard diameter of the central volume 42, e.g., one-third to one-tenth or less of such standard diameter. As another example, the narrowing or closing can be achieved by chemically or thermally fusing the end 38 to form a closed mass as a tip. Techniques such as those described in U.S. Patent Application Publication No. 2015 / 0374475, which is incorporated herein by reference in its entirety, could be used. End 40 is likewise preferably narrowed or closed to form a tube having a narrow passage therethrough. Closure element 30 thus has an intermediate portion 44 of mesh 34 in the longitudinal direction between narrowed or closed end 38 and end 40, with volume 42 being within intermediate portion 44 and bounded by mesh 34.

[0021] In certain embodiments, the end 38 (and possibly the other end(s) of the closure elements 30, 32) is or includes a radiopaque marker. For example, such a marker may be a tube of a biocompatible metal (e.g., gold, platinum, tungsten-based metal, zinc-based metal, iron-based metal, and / or magnesium-based metal) or a suitable bioabsorbable material. An example marker has an open end and an interior and exterior, and in some embodiments includes a side opening through the side wall. It is encased by the mesh 34 of the particular closure element. Such integration is possible if the mesh 34 is capable of existing as a fluid mass and can undergo a phase change to a solid mass. Once the end portion of the mesh 34 has been treated (e.g., by heating, chemical hardening, or application of an electric or magnetic field) to become a fluid mass, pressure is applied to direct the fluid mass, for example, into or around the tubular marker in or through the open end and / or side opening. The fluid mass then undergoes a phase change to a solid (by cooling), resulting in the solid mesh material encasing the tubular marker. The interior of the marker may be entirely occupied by the mass, or a lumen may be left through the encased marker. In this manner, the marker is firmly anchored to the mesh 34 while any rough edges on the marker are covered. Such a marker may serve to indicate when one or both of the closure elements 30, 32 are pulled together, for example, to indicate a compressed or crushed mesh shape and to indicate if the mesh compression is distorted.

[0022] The closure element 30 in the illustrated embodiment is double inverted, meaning that each end 38, 40 is inverted so that the narrowed or closed portion faces or is within the volume 42. For example, the closure element 30 may be made by forming a sheet of mesh 34 into the shape of a tube with open ends (destined to be ends 38 and 40). In the tubular form, an exterior surface 46 with an edge 47 surrounds an interior space that will form the volume 42 of the closure member 30. An interior surface 48 faces the volume 42. Forming the inverted end includes folding the edge 47 into the interior space so that the edge is inside a portion of the interior surface 48. The ends are narrowed or closed as mentioned above (e.g., by heat shrinking, chemical treatment) so that the edge remains within the volume 42 of the occluder 30. In such an embodiment, a portion of exterior 46 of mesh 34 folds over, with end 38 everted into volume 42, and the bent or folded portion of exterior 46 forms exterior end 50 of occluder 30. It should be understood that the narrowing or closure of the end(s) may occur prior to or after eversion. As noted, because occlusion element 30 is double everted, end 40 is also everted identically or similarly to end 38.

[0023] In certain embodiments, some or all of the closure element 30 includes a sheet or mass of therapeutic or healing material 54 that can at least partially block fluid flow and / or support tissue growth to contribute to or assist the healing process. By way of example, a sheet, layer, or other portion of SIS (small intestine submucosa) may be placed as a lining on the interior of the mesh 34 (e.g., within volume 42) or may be secured to an exterior portion of the mesh 34. In FIG. 1, layer 54 is shown secured to the exterior of the mesh 34 such that it covers most or all of the surface around edge 40, or at least such that when the closure element 30 is flattened as discussed further below, the sheet 54 covers at least a portion of the tissue opening to be repaired or healed.

[0024] The closure element 32 is for proximal placement, i.e., placement on the side of the tissue surface first reached or approached by the placement device 24, and is similar to the closure element 30 in certain embodiments. For example, the closure element may be the same or essentially the same as the closure element 30 described above, and may have a mesh 34 as a body enclosing a central volume 52 with a first end 58 and a second end 60, which in the illustrated embodiment are narrowed or closed. In certain embodiments, the closure element 32 is similar to the closure element 30 described above, but has one inverted end 58 and one non-inverted end 60 (see FIGS. 1 and 4). The end 58 is inverted and closed or narrowed as described above. Although the end 60 is closed or narrowed as described above, the outer surface of the mesh 34 of the closure element 32 is not folded over itself, such that the end 60 does not extend or face into the volume 52. Rather, in this embodiment, the end 60 faces generally away from the volume 52. In certain embodiments, ends 58 and 60 are aligned along a common longitudinal axis extending through volume 52. It should be understood that in other embodiments, closure element 32 is double inverted like closure element 30, rather than single inverted.

[0025] The closure elements 30 and 32 are connected by a filament or tether 64 in certain embodiments. The tether 64 has two ends 66, 68 that are enlarged like knots or beads to be at least slightly larger than any openings through the ends 38, 40, 58, 60 of the closure elements 30, 32. Additional beads, knots, or other enlargements may be present between the ends 66 and 68 for adjustability when locking the closure elements 30, 32. The tether 64 extends through the end 38 of the closure element 30, and the end 66 of the tether 64 is outside the volume 42 and is within, engaged with, or beyond the end 38 of the element 30 so as to be secured or otherwise connected to the end 38. From the end 38, the tether 64 passes through the ends 38 and 40 and through the volume 42 of the element 30. From the closure element 30, the tether 64 extends through the end 58 of the closure element 32 into the volume 52, spanning any gap that may exist between the closure element 30 and the closure element 32. It should be understood that in embodiments in which the tether 64 is secured to the end 38 of the closure element 30, other fastening methods, such as adhesives or fusing, could be used to secure the tether 64 to the end 38 or another portion of the closure element 30. In the illustrated embodiment, the tether 64 is connected to the end 38 at a point within the interior space created by the inverted fold of the end 38. The tether 64 is not fixed relative to the end 40 of the closure element 30, and can be moved through the end 40 by pulling. Similarly, the tether 64 is not fixed to the end 58 of the closure element 32, and can be moved through the end 58, and the end 68 of the tether 64 can be forced through the end 60 of the closure element 32 by pulling. A pull applied to tether 64 can collapse closure element 30 towards closure element 32 and against the tissue between members 30 and 32 .

[0026] As discussed further below, a tension or control line 70 is looped through the end 68 of the tether 64 and threaded into the closure element 32 and out of the closure element 32 via an opening through the end 50 of the closure element 32. In certain embodiments, the line 70 passes through a bend, hole, or knot in the tether 64. When the line 70 is pulled or otherwise tensioned, it tensions the tether 64, thereby pulling the end 38 of the closure member 30 and pulling or flattening the closure member 30 against the tissue and closure member 32. The control line 70 is also part of the procedure for flattening the closure element 32 against the tissue, as discussed further below.

[0027] In an alternative embodiment, a filament in the form of a solid stem 64' is provided in place of the tether 64. The stem 64' has an elongated body 65' with a flattened end 66' and an opposing end 68' in the illustrated embodiment. In the illustrated embodiment, the body 65' and the ends 66' and 68' are monolithic, e.g., formed or fabricated as a single piece of the same material. Such material is preferably a bioabsorbable material having sufficient strength to hold the two closure elements 30, 32 together for a sufficient period of time to allow the closure elements 30, 32 to be engulfed and sealed by body tissue. The body 65' includes one or more projections 69' that act as stop points or barbs between the ends 68' and the flattened end 66'. In certain embodiments, the projections 69' have a surface facing the flattened end 66' that is perpendicular or forms an acute angle with the longitudinal axis of the body 65' to form a stop surface as discussed further below. End 68' is adapted to be engaged with a suture or control line 70 (discussed further below), e.g., having a loop, curve, or eye through which control line 70 can extend and / or through which control line 70 can be attached to body 65'. Flattened end 66', in certain embodiments, is substantially planar along a surface 71' adjacent body 65' and convexly curved along a surface 72' opposite surface 71'.

[0028] In this embodiment, the stem filament 64' is secured to or otherwise engaged with the closure element 30. For example, the body 65' is inserted through the closed or narrowed end 38 of the closure element 30 such that the flattened end 66' abuts a portion of the closure element 30 distal to the inverted end 38 to anchor the stem 64 to the closure element 30. The body 65' initially extends through the closure element 30, into or through the closure element 32, such that when placed in the body, the body 65' extends through and away from the end 60 of the closure element 32. In certain embodiments, the body 65' can extend through the ends 38, 40, 58, 60 of the closure elements 30, 32, while in other embodiments the body 65' need not pass through one or more of those ends, but may pass through a mesh of one or more portions of the closure elements 30, 32.

[0029] When the closure element 22 is first prepared, the end 68 of the tether 64 or the protrusion 69' of the body 62' extends at least through the end 38 and into the volume 42 of the closure element 30. A control line 70 extends from the tether 64 or the body 65' and, depending on how far the tether 64 or the body 65' is initially placed through the closure elements 30 / 32, the line 70 extends through the closure elements 30 and 32 and exits the closure element 32 via the narrowed or closed end 60. When the closure elements 30, 32 are placed, they are compressed and the tether 64 or stem 64' will hold one or both of them in compression. For example, once the closure element 30 is deployed (as discussed further below), the line 70 can be pulled, which in turn pulls the tether 64 or stem 64', forcing the end 66 of the tether 64 or one or more prongs 69' of the body 65' through the end 60 or another portion of the closure element 32. The end 66 of the tether 64 or the flattened end 66' of the stem 64' pulls the distal portion (or end 38) of the closure element 30 towards the proximal portion (or end 40) of the closure element 30, compressing the closure element 30. The one or more prongs 69' can engage the proximal portion (or end 40) of the closure element 30 to prevent redeployment of the closure element 30. Similarly, further pulling of the line 70 may pull the body 65' through the distal portion (or end 58) of the closure element 32 and / or through the proximal portion (or end 60) of the closure element 32, compressing the closure element 32 against itself and / or toward the closure element 30, ultimately securing the closure device 22 against tissue. The tether 64 or stem 64' is thus spanned within and between the closure elements 30 and 32, with the end 66 of the tether 64 or the flattened end 66 of the stem 64' distally outside the closure element 30 and the at least one prong 69' of the body 65' proximally outside the closure element 32.

[0030] The inventors have further found that some uses of the closure device 22 have the advantage of reducing the compressed height of one or both of the closure elements 30, 32 when in use. "Height" in this context means the dimension measured outward from the tissue to which the closure element is applied. To accommodate situations where space is at a minimum or where a smaller occluder is otherwise desired, the closure element 30 is prepared such that the ends 38 and 40 are offset from one another within the volume 42. As seen in FIG. 5, the ends 38 and 40 are inverted and narrowed or closed as described above, but are arranged asymmetrically, with each end 38 and 40 leaning to one side of the other. This allows the closure element 30 to be compressed such that the ends 38 and 40 move past one another with less or no contact or other interference with one another compared to the configurations described above where the ends 38 and 40 are aligned or coaxial. In this embodiment, the tether 64 or stem 64' is secured to end 38 as discussed above, but does not extend through end 40. Rather, the tether or stem 64' passes through mesh 34 beside end 40 and onto the side of closure element 32 as described above. It should be understood that a similar configuration could also or instead be applied to closure element 32.

[0031] In another embodiment (FIG. 6), the closure element 30 has ends 38 and 40 that are aligned, but one of the ends 38 or 40 has a larger diameter than the other. For example, the end 40 is everted as described above and narrowed to a given diameter. The end 38 is everted as described above and narrowed to a diameter smaller than the diameter of the narrowed end 40. The tether 64 or stem 64' extends through both the end 38 and the end 40. When the closure element 30 is compressed, the end 38 is pulled toward the end 40, and the end 38 at least partially enters the end 40. It is to be understood that in other embodiments, the end 40 may be smaller than the end 38, and similar configuration(s) may also or instead be applied to the closure element 32.

[0032] In another embodiment (FIG. 7), the closure element 30 is not a double inverted member, but instead is a single inverted member like the illustrated embodiment of the closure element 32. Thus, in this embodiment, the end 38 is inverted as discussed above, but the end 40 is not inverted, the same as the end 60 of the closure element 32. One or both of the ends 58 and 60 of the closure element 32 have a diameter larger than the diameter of the end 40 of the closure element 30, as discussed above. The tether 64 or stem 64' initially passes through the ends 40 and 58, respectively, and during use, passes through the end 60 in this embodiment. When the closure elements 30, 32 are compressed, the end 40 of the closure element 32 passes through the tissue opening to be closed or sealed and enters one or both of the ends 58 and 60 of the closure element 32.

[0033] The closure device 22 may be placed in the body in a minimally invasive manner by gaining percutaneous access to a blood vessel, organ, or other part of the body and advancing the closure device 22 to the desired location using or through a catheter or other tube. It should be understood that the closure device 22 could also be placed in the body at the desired location via open surgery or other procedures. One embodiment of a placement device 24 for minimally invasive placement of the closure device 22 is shown diagrammatically in FIGS. 8-13. This embodiment of the placement device 24 is intended for insertion through a previously placed sheath 100 that allows access to or placement through an opening H in the tissue T to be closed. In this embodiment, the sheath 100 extends from inside the right atrial appendage (RAA) through the opening H in the tissue T into the pericardial space, and the balloon 101 of the sheath 100 is inflated to anchor the sheath 100.

[0034] The device 24 includes tubular members 102, 104, and 106, to which a handle 108 is connected in the illustrated embodiment. As discussed further below, the device 24 is inserted through a delivery sheath 100 advanced through and anchored to bore H. The delivery sheath 100 is a 14 French tubular sheath in one embodiment. In this embodiment, the tubular member 102 is a 14 French peel-away type tube around the distal end of the member 104, which can be a 12 French delivery sheath. The member 106 is a pusher member and / or guide cannula that is slidable within the member 104. Thus, the member 104 is initially at least partially within the peel-away member 102, which is within the member 104. In certain embodiments, an additional tubular member 110 extending through the member 106 is provided as a guide cannula for the control line 70. The control line 70 extends through the member 110, and in one particular embodiment, the line 70 is a thin braided stainless steel cable. The line 70 has a proximal end connected to the handle 108, extends out the open end of the member 110, through the end 60 of the closure element 32, loops through the tether 64 or stem 64' (described above), and folds back through the end 60 and into the member 100. In this manner, the line 70 is initially doubled within the member 110 so that the free end 111 is within the member 110 and faces generally proximally. The member 104 can fit within the sheath 100 while still containing the closure device 22. In the initial (pre-use) configuration, the closure element 30 is within the member 102, and the closure element 32 is within the member 104, directly adjacent or closely adjacent to the closure element 30. The pusher member 106 is initially proximal or rearward of the closure element 32. As the device 24 is inserted into the delivery sheath 100, the peel-away member 102 is pulled away and peeled away, leaving the closure element 30 within the sheath 100, and the delivery member 104 (containing the closure element 32) also remains behind the closure element 30 within the sheath 100.

[0035] Various embodiments of the system 20 (e.g., the placement device 24 and / or one or both of the closure elements 30, 32) may be configured to accommodate passage of a wire guide. For example, such a wire guide may extend through each closure element 30, 32, through the placement device 24, and into the sheath 100 in the bore H. The wire guide may extend alongside or within the pusher member 106, or through a separate lumen through or alongside the device 24. If a wire guide passes through the closure elements 30, 32, it may pass through the mesh 34 at a location(s) other than one or more of the ends 38, 40, 58, 60. Such a wire guide may serve to assist in aligning the closure elements 30, 23, or provide a navigation path that can be left behind if the system 20 is abandoned and the closure process needs to be restarted. In such a case, the wire guide provides a guide path for a subsequent closure device to access and close the foramen H.

[0036] As noted, the illustrated embodiment of the sheath 100 includes a balloon 101 at or near the distal end for anchoring the delivery sheath 100. When the sheath 100 is extended through the aperture to deliver a therapeutic device or composition or for other purposes, the balloon 101 is inflated on the distal side of the aperture to anchor the delivery sheath 100 in place. Once the sheath 100 is so anchored and any desired procedures through the sheath 100 have been performed, the user inserts the placement device 24 in its initial configuration into the sheath 100 and the peel-away member 102 as shown above. Such insertion and advancement into the sheath 100 can be accomplished over a wire guide passed through or along the device 24. The device 24 without the member 102 (i.e., members 104 and 106 connected to the handle 108 and including the features described above in members 104 and / or 106) is then pushed through the sheath 100 such that the closure element 30 emerges from the distal end of the sheath 100. In certain embodiments, the closure element 30 is pushed by advancing the delivery member 104 forward from or with the handle 108 such that the closure element 30 is pushed out of the sheath 100. The member 104 and / or its connected handle 108 are desirably locked to the sheath 100 outside the patient's body such that the deployment of the closure element 30 can be visualized (e.g., by fluoroscopy).

[0037] When closure element 30 emerges from member 104, distal end 38 is generally away from tissue T through which hole H extends. End 40 is oriented toward tissue T such that outer end 40 (having folded mesh and, in some embodiments, healing material, as described above) faces hole H. Tension is maintained in tether 64 by pulling back at least slightly on member 100 (which may be connected or locked to members 104 and / or 106). Such pulling provides tension through control line 70 to tether 64 and to end 38 of closure element 30, flattening it against the distal end of sheath 100.

[0038] At this point, balloon 101 is deflated to allow retraction of sheath 100 from hole H. Sheath 100 and device 24 are retracted together until closure element 30 engages the distal surface of tissue T (e.g., the pericardial cavity side of the RAA wall). Again, the user can visualize the site to ensure closure element 30 is pressed against the tissue and / or to ensure sheath 100 is outside hole H (e.g., entirely on the cardiac side of the RAA wall). Member 104 and sheath 100 are then further retracted to expose and deploy an intermediate portion of tether 64 while member 106 (e.g., integral with member 110) and line 70 are maintained in position. The user can verify (by visualization under fluoroscopy) the clearance between closure element 30 and the distal end of member 104 and / or that the distal end of member 104 is clear of the RAA wall. Again, while maintaining the position of member 106 (integral with member 110) and line 70, member 104 and sheath 100 are further retracted to expose and deploy occlusion element 32 from within member 104. Visualization of such deployment may be performed.

[0039] With the closure element 32 clear of the member 104 and its distal end 58 generally facing the tissue T, the practitioner advances the pusher member 106 against the proximal end 60 of the closure element 32 while maintaining the position of the line 70. The member 106 pushes the end 60 past the enlarged end 68 of the tether 64, forcing the end 68 through the end 60 and flattening the closure element 32. As mentioned above, because the enlarged end 68 of the tether 64 is larger than the opening through the end 60 of the closure element 32, once the tether end 68 is pushed through the end 60, the closure device 22 is locked. That is, the closure elements 30 and 32 are pressed flat against their respective sides of the tissue T, and the tether 64 locks them together, preventing the end of the closure element from slipping past the enlarged ends 66, 68 of the tether 64.

[0040] With the closure device 22 locked, the line 70 is held in place while the member 110 is retracted sufficiently to allow the free end 111 of the line 70 to exit the distal end of the member 110. The line 70 is looped with the free end 111 within the member 110 as mentioned above, and in certain embodiments, the free end 111 bends outward upon being freed from the member 110. With the free end 111 outside the member 110, the line 70 is retracted (e.g., via the handle 108). The free end 111 is pulled from the closure element 32 through the end 68 of the tether 64 and away from the treatment site. The remainder of the device 24 (including members 104 and 106) and the sheath 100 are then retracted over the wire guide, if one is present. The closure device 22 remains in the locked state mentioned above to allow for healing of the foramen H.

[0041] One exemplary embodiment of the operative (distal) end of device 24 is shown diagrammatically in FIG. 13. A peel-away sheath 102 is shown as being outermost and contains distal closure element 30. An inner catheter or tube 104 is within peel-away sheath 102 and its distal end is closely adjacent closure element 30. A proximal closure element 32 is within inner catheter or tube 104. A pusher member or guide tube or cannula 106 is within inner catheter or tube 104 and, in certain embodiments, a cannula 110 is provided for control line 70. Control line 70 extends through member 106 and / or member 110 and loops back around end 68 of tether 64 to member 106. Proximally, each of members 104, 106 (and member 110, if present) and line 70 are connected to a handle 108.

[0042] The representation of the handle 108 shows that the pusher catheter 106 is connected directly to the handle with the peel away sheath 102 and inner catheter or tube 104 surrounding the pusher catheter 106. In certain embodiments, a lock 120 connects the handle 108 to the tube 104. The connection of the handle 108 to the line 70 is not shown in the figures. In the illustrated embodiment, the handle 108 includes a body 150 shaped and configured to be held and manipulated by hand. There are three actuators located on or within the handle 108. The control line actuator 152 can include a pull ring and a shaft connected to the line 70. The actuator 152 holds the line 70 in place and by pulling the actuator 152, the line 70 is pulled or placed under tension. Additional actuators may be connected to the members 104 and / or 106 to allow for their relative movement relative to each other or other parts of the device 24. It should be understood that one or more actuators may be assembled in series to essentially automate several operations in one operation.

[0043] One problem that has arisen with placing a delivery sheath or similar device through a tissue opening is that as the sheath is retracted, friction of the retracting sheath stretches or displaces the tissue plane through which the opening extends. For example, in a procedure where a hole for the delivery device is formed in the thin wall of the right atrial appendage, as the sheath is retracted through the hole, the atrial appendage wall tends to invaginate into the right atrium, which is undesirable. To solve this problem, an outer sheath 170 may be placed over the delivery sheath (100 in the illustrated embodiment) that is anchored by the balloon 101. While the balloon 101 is inflated, the sheath 170 is moved to a position where its distal end is just proximal to the hole (e.g., engaging or closely adjacent to the tissue around the hole). As the delivery sheath 100 is retracted (following deflation of the balloon 101), the distal end of the sheath 170 supports the wall of the tissue plane through which the sheath 100 is being withdrawn.

[0044] Alternatively, the delivery sheath 100 may include a lumen (which may be the same or different from the lumen containing the device 24) and a communicating side port 180 disposed below the balloon 101 a sufficient distance so that the balloon 101 is at least partially below the inner tissue wall surface when inflated and anchored to the outer tissue wall surface. A wire 182 made of a shape memory material (e.g., Nitinol) resides within the lumen in an undeployed or constrained shape or configuration. When retraction of the sheath 100 is desired, the wire 182 is advanced through the lumen and at least partially out of the port 180. When the wire 182 emerges from the port 180, it assumes a deployed shape, e.g., an deployed helical shape. As the wire 182 is advanced, it presses against the wall of the tissue plane, providing counter support for the tissue as the sheath 100 is retracted.

[0045] It is understood that port 180 may be used for other purposes in addition to or instead of placement of wire 182. For example, once sheath 100 is in place or adjacent to it, contrast media may be injected through the lumen and side port 180 to aid in visualization of the hole or tissue surrounding the hole. Similarly, side port 180 may be used as a water flushing port.

[0046] The above discussion of closure of holes in organs or other tissues is generally applicable to many types of openings, whether the opening is naturally occurring (e.g., a fistula) or artificially occurring (e.g., a hole through a wound or a hole for passage of a therapeutic or diagnostic device). In certain embodiments, as noted above, the devices and methods described herein can be used to repair a hole through the right atrial appendage that has been opened to allow delivery of a therapeutic device to the heart. In such embodiments, tissue T is a portion of the right atrial appendage that separates the interior of the appendage from the pericardial cavity.

[0047] While the subject matter has been illustrated in the drawings by way of example and described in detail in the foregoing description, it is to be understood that the drawings and description are to be interpreted as illustrative and not restrictive in nature, that only the preferred embodiment(s) have been shown and described, and that all changes and modifications that come within the spirit of the disclosure are desired to be protected. It is to be understood that structures, methods, and other features that are particularly described with respect to one embodiment can also be used or incorporated in or with other embodiments. [Explanation of symbols]

[0048] 20. SYSTEM FOR CLOSING TISSUE HOLES 22 Closing device 24 Installation equipment 30 First or Distal Closure Element 32 Second or proximal closure element 34 Mesh 36 Gap 37 Strands or similar straight members 38 1st end 40 2nd end 42 Central volume 44 Middle part 46 External 47 Relationship 48 Internal surface 50 External end 52 Central volume 54 Therapeutic or healing materials in sheet or block form 58 1st end 60 2nd end 64 Tether 64' solid stem 65' long and slender body 66, 68 end 66' flat end 68' Flat end 66' opposite end 69' protrusion 70 Tension or control lines 71' the surface of the flattened end 66' adjacent to the body 65' 72' Surface opposite to surface 71' 100 Sheath 101 Balloon 102, 104, 106, 110 Tubular members 108 Handle 111 Free end 120 Rock 150 Handle body 152 Control Line Actuator 170 Outer sheath 180 Side Port 182 Wire H hole T organization

Claims

1. 1. A closure for an opening in tissue, comprising: a first closure element having a first mesh enclosure having a distal first narrowed end and a proximal second narrowed end and a central volume, the first narrowed end being inverted such that the first narrowed end is located within the central volume of the first mesh enclosure, the first narrowed end being surrounded by an exterior surface of the first mesh enclosure; a second closure element having a second mesh enclosure, the second mesh enclosure having a distal third narrowed end and a proximal fourth narrowed end and a central volume, the second closure element being inverted such that the third narrowed end is located within the central volume of the second mesh enclosure, the third narrowed end being surrounded by an exterior surface of the second mesh enclosure; a tether connecting the first and second closure elements in an initial configuration prior to delivery of the first and second closure elements to the opening, the tether having a first enlarged end and a second enlarged end, the first enlarged end of the tether being adjacent to or joined to the first narrowed end and outside of the first closure element, the distal first narrowed end of the first closure element being adapted to anchor the first enlarged end of the tether, the second enlarged end of the tether being within the central volume of the second closure element and extending through the first narrowed end, the second narrowed end, and the third narrowed end; It is equipped with The first closure element is adapted to engage a distal surface of the tissue having the opening, the second closure element is adapted to engage a proximal surface of the tissue, and the tether is adapted to pass through the opening.

2. 10. The occluder of claim 1, further comprising a sheet of bioabsorbable material secured to the first closure element adjacent to or over the second narrowed end.

3. The closure of claim 2 , wherein the sheet is secured to an exterior portion of the first mesh enclosure.

4. The occluder of claim 1 , wherein each of the first and second enlarged ends of the tether comprises a bead or a knot.

5. The occluder of claim 1 , further comprising a control wire looped through the second enlarged end of the tether.

6. The occluder of claim 5 , wherein the control wire passes through the fourth narrowed end.

7. The occluder of claim 1 housed within a delivery device.

8. The occluder of claim 1 , wherein the first narrowed end and the second narrowed end are aligned with one another.

9. The occluder of claim 1 , wherein the third narrowed end and the fourth narrowed end are aligned with one another.

10. The occluder of claim 1 , wherein the first narrowed end and the second narrowed end are laterally offset relative to one another.

11. 2. The obturator of claim 1, wherein one of the first narrowed end and the second narrowed end is larger in diameter than the other of the first narrowed end and the second narrowed end.

12. 1. A device for closing an opening in a right atrial appendage of a patient, comprising: a delivery device having a first peel-away catheter, a second tube within the first peel-away catheter, and a pusher tube within the second tube; The occluder of claim 1 housed within the delivery device; An apparatus comprising:

13. 13. The device of claim 12, wherein the first closure element is within the first peel-away catheter and the second closure element is within the second lumen.

14. The device of claim 12 , further comprising a control line looped through the second enlarged end of the tether.

15. 15. The apparatus of claim 14, further comprising a control cannula extending through said pusher tube, said control line extending through said control cannula.

16. 16. The device of claim 15, wherein the control line extends from the control cannula and folds back from the second enlarged end of the tether to the control cannula such that a free end of the control line is within the control cannula.

Citation Information

Patent Citations

  • Hernia curing prosthesis

    JP2002209901A

  • Delivery / retrieval system for septal occluder

    JP2007526087A

  • Expandable occlusion device and method

    JP2014529441A

  • Closure device for tissue opening - Patent application

    JP2020521537A

  • Patent foramen ovale closure system

    US20050119675A1